What is Amyloidosis?
Most amyloidosis diseases have different treatments; therefore, the correct diagnosis is extremely important.
Featured Patient Story
As we look toward the future

Glenn Dale Galloway
Latest Headlines
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid CardiomyopathyResults From ATTRibute-CM and Its Open-Label Extension

November 12, 2025
JAMA Cardiol
Published Online: November 8, 2025
Today at the AHA congress in New Orleans, BridgeBio presented data showing that acoramidis significantly reduces all-cause mortality (through month 42) in people living with hereditary ATTR-CM population, with specific benefit noted in those living with...
Calendar & Upcoming Events
Looking Back at 2025 and Preparing for what’s next in 2026

Webinar Session: Wednesday, December 24th, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Looking Back at 2025 and Preparing for what’s next in 2026
Speaker: Dr. Stacey Goodman, Vanderbilt University


Living Forward with Amyloidosis: Practical tips that make a difference

Webinar Session: Wednesday, December 17th, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Living Forward with Amyloidosis: Practical tips that make a difference
Speaker: Sally Cox, AL amyloidosis patient and leader of the Pacific NW Amyloidosis Support Group


Webinar: Heart Failure in Amyloidosis: Recognizing Symptoms and Taking Action

Webinar Session: Wednesday, December 3rd, 2025 at 6 PM (ET) Zoom Meeting
(These sessions will not be recorded due to patient involvement and HIPAA laws)
To Register HERE
Heart Failure in Amyloidosis: Recognizing Symptoms and Taking Action
Speaker: Dr. Nitasha Sarswat, cardiologist at UChicago Medicine


Amyloidosis Videos
Featured Product
Notecards







